---
title: Pharmnos Lite Stage 3 Independent Financial Review
date: 2026-11-07
status: REJECTED — independent financial re-review
---

# Review boundary

This record is reserved for an independent financial/business-integrity
reviewer to inspect the target-bound purchase and sales evidence, exact-decimal
reconciliation, ledger/stock effects, valuation status, GST policy boundaries,
and unsupported statutory claims.

The independent financial reviewer accepted only the bounded exercised Sales
path and the target-bound nature of the 16/16 Purchase GST evidence.

| Criterion | Decision | Classification |
|---|---|---|
| ST3-D GST boundaries | PARTIAL | Owner-approved current-release policy is recorded; unsupported inclusive tax, freight/discount allocation, and automated ITC remain outside scope. |
| ST3-E purchase, receipt, inventory, valuation | PARTIAL | Paid/free quantities are implemented as separate fields and total physical quantity posts to stock; target-bound persisted readback remains open. |
| ST3-F Sales path | ACCEPT — bounded scope | Current-source Sales finalization, GST, stock, customer ledger, and immutability evidence passed for the exercised scenario. |
| ST3-G ledger/payment/retry | REJECT | Runtime retry/rollback passed, but payment/ledger constraints and complete payment readbacks remain insufficient. |
| ST3-J independent financial acceptance | REJECT | Mandatory independent financial acceptance is not established. |

Overall financial disposition: **REJECTED** for final system-readiness
acceptance. Synthetic fixtures are not professional or statutory confirmation.

The current-source disposable run now provides persisted 16/16 Purchase GST
reconciliation for accepted GST snapshots, invoice/line totals, stock
movements, supplier ledger, audit/idempotency metadata, retries, rollback,
and tenant isolation. This closes the earlier runtime-evidence gap for the
exercised paths but does not close the policy or professional-review blockers.
Independent financial re-review of `26-authorized-disposable-runtime-evidence.json`
confirmed the bounded persisted evidence but **REJECTED final Stage 3
financial acceptance**. Remaining blockers are paid/free persisted readback,
acquisition-cost/ITC governance, complete payment/ledger constraints, browser
E2E, and provider recovery evidence.

The current-source rerun in
`27-current-source-targeted-runtime-evidence.json` preserves that bounded
runtime result after the supplier-document locking and finalized-purchase
immutability changes. It does not change the independent financial
disposition or provide professional/statutory confirmation.

## Controlled financial-closure re-review

The fresh independent financial review returned:

- ST3-D: **REJECT** — current-release GST policy and professional/statutory
  boundaries remain unresolved.
- ST3-E: **REJECT** — controlled recoverable, nonrecoverable, partial, and
  pending valuation behavior is implemented and tested, but free-quantity,
  receipt semantics, acquisition-cost governance, and statutory eligibility
  remain unaccepted.
- ST3-F: **ACCEPT — bounded current-release scope** for the exercised
  action-path scenarios; this is not browser acceptance.
- ST3-G: **REJECT** — overpayment rejection and retry behavior pass, but
  complete payment readbacks, universal posting uniqueness, and broader
  ledger semantics remain insufficiently evidenced.
- ST3-J: **REJECT** — mandatory final independent financial acceptance is not
  established.

The owner-confirmed product policy is the current-release baseline. External
professional confirmation is not an internal acceptance gate and no
professional endorsement is claimed. The reviewer did not reject solely
because of deferred V2 capabilities; the remaining rejection is based on
current-release evidence and reconciliation gaps.
